Subscribe To
cidara therapeutics provides corporate update and reports third quarter 2023 financial results
SAN DIEGO, Nov. 02, 2023 (GLOBE NEWSWIRE) — cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology...
November 2, 2023, 8:15 pm
cidara therapeutics and mundipharma receive positive chmp opinion for rezafungin for the treatment of invasive candidiasis in adults(1)
The opinion was based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the STRIVE Phase II clinical trials and e...
October 13, 2023, 2:34 pm
cidara therapeutics reports inducement grant under nasdaq listing rule 5635(c)(4)
SAN DIEGO, Sept. 29, 2023 (GLOBE NEWSWIRE) — cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnolog...
September 29, 2023, 8:51 pm
cidara to present at the 25th annual h.c. wainwright global investment conference
SAN DIEGO, Sept. 06, 2023 (GLOBE NEWSWIRE) — cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnolog...
September 6, 2023, 8:05 pm
cidara shares surge 18.5% as j&j unit janssen takes lead on flu drug
Shares of cidara Therapeutics soared 18.5% in early New York trading, buoyed by news that Janssen Pharm...
September 6, 2023, 9:36 am
cidara therapeutics: leveraging antifungals to move into cancer therapy
cidara Therapeutics is a biotech company with an approved antifungal drug, Rezzayo, but its sales are n...
August 10, 2023, 5:50 pm
cidara therapeutics (cdtx) reports q2 loss, lags revenue estimates
cidara Therapeutics (CDTX) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus...
August 3, 2023, 6:46 pm
cidara therapeutics provides update on status of ongoing cd388 influenza program
SAN DIEGO, July 20, 2023 (GLOBE NEWSWIRE) — cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology...
July 20, 2023, 9:00 pm
Buy cidara therapeutics for data readout and european foothold
With their first product approval last quarter, Europe should follow suit. Their U.S. partner is experienced in commercializing antibiotics....
May 21, 2023, 4:41 am
cidara therapeutics provides corporate update and reports first quarter 2023 financial results
SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) — cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology ...
May 11, 2023, 8:37 pm
cidara therapeutics (cdtx) reports q4 loss, misses revenue estimates
cidara Therapeutics (CDTX) delivered earnings and revenue surprises of -1,800% and 45.06%, respectively...
March 23, 2023, 9:54 am
Why is cidara therapeutics (cdtx) stock down 12% today?
cidara Therapeutics (NASDAQ: CDTX ) stock is falling on Thursday despite the immunotherapy company gett...
March 23, 2023, 9:16 am
cidara to present at esmo targeted anticancer therapies congress
SAN DIEGO, Feb. 28, 2023 (GLOBE NEWSWIRE) -- cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology ...
February 28, 2023, 8:00 am
cidara therapeutics: fda approval dead ahead
Today, we are putting the spotlight on small biotech concern cidara Therapeutics for the first time in ...
January 30, 2023, 5:23 am
cidara therapeutics to present at the 24th annual h.c. wainwright global investment conference
SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology...
September 6, 2022, 8:00 am
cidara therapeutics (cdtx) reports q2 loss, lags revenue estimates
cidara Therapeutics (CDTX) delivered earnings and revenue surprises of 32.14% and 14.85%, respectively,...
August 9, 2022, 9:04 pm
cidara therapeutics (cdtx) reports q4 loss, tops revenue estimates
cidara Therapeutics (CDTX) delivered earnings and revenue surprises of 21.21% and 84.78%, respectively,...
March 7, 2022, 8:16 pm
Fda clears cidara therapeutics' phase 1 trial for immunotherapeutic antiviral for influenza
The FDA has signed off cidara Therapeutics Inc's (NASDAQ: CDTX) Investigational New Drug (IND) applic...
February 14, 2022, 10:12 am
Fda clears cidara therapeutics' phase 1 trial for immunotherapeutic antiviral for influenza
The FDA has signed off cidara Therapeutics Inc's (NASDAQ: CDTX) Investigational New Drug (IND) applic...
February 14, 2022, 10:12 am
Fda clears cidara therapeutics' phase 1 trial for immunotherapeutic antiviral for influenza
The FDA has signed off cidara Therapeutics Inc's (NASDAQ: CDTX) Investigational New Drug (IND) applic...
February 14, 2022, 10:12 am